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Previous studies have shown that rabbit hearts subjected to in vivo left ventricular myocardial infarction and subsequent ex vivo perfusion respond to A'-formylmethionyl-leucylphenylalanine (fMLP) with enhanced eicosanoid synthesis. This synthetic response occurs primarily in the right cardiac atrium, a site distant from the injury, and is not the result of increased enzymatic capacity for arachidonate metabolism. To further investigate the mechanism of this enhanced synthetic response, [ been thought important in the pathophysiology of myocardial infarction. Several groups have shown increased production of thromboxane, prostaglandin E^ (PGE2), prostacyclin, and 12-HETE by tissue from infarcted hearts.
1 " 3 Furthermore, the combined cyclooxygenase-lipoxygenase inhibitor BW-755C has been shown to both decrease infarct size and reduce the incidence of ventricular dysrhythmias. 3 - 5 Enhanced arachidonate metabolism in myocardial infarction has generally been attributed to inflammatory cells. The leukocytes that invade injured tissue are prodigious in their capacity for eicosanoid synthesis, 6 -8 and the eicosanoids produced by these cells are thought to exert their effect on adjacent myocardium. To test the hypothesis that inflammatory cells are responsible for exaggerated eicosanoid synthesis following cardiac injury, we have previously developed a model of rabbit myocardial infarction in which hearts were initially subjected to in vivo left ventricular myocardial infarction, followed 1-4 days later by ex vivo perfusion. When challenged with intracoronary Af-formylmethionyl-leucyl-phenylalanine (fMLP), an agonist known to stimulate eicosanoid synthesis by inflammatory cells, 9 the infarcted hearts were found to synthesize large quantities of PGE2, prostacyclin, thromboxane, and leukotrienes compared with normal controls. 10 -11 Surprisingly, the enhanced prostanoid synthetic response observed after infarction occurred predominantly in the right atrium, a site distant from the left ventricular infarct and devoid of histologically apparent inflammatory cells. 12 Enzyme kinetic analysis of both infarcted and normal hearts revealed that while arachidonate metabolizing enzymes are concentrated in the right atrium, the enhanced synthesis observed in infarcted hearts was not due to 216 Circulation Research Vol 65, Mo 1, July 1989 increased enzymatic capacity for arachidonate metabolism. 12 These results suggest that enhanced fMLP-stimulated eicosanoid synthesis in the right atrium is due to increased availability of arachidonate for eicosanoid synthesis. Such an increase in substrate availability might be the result of alterations in fMLP receptor number or affinity or alterations in membrane phospholipase activity.
In the current study we have characterized the expression and distribution of formylated peptide receptors in intact tissue sections of control and infarcted rabbit hearts. Quantitative binding studies demonstrated a saturable fMLP binding site in right atrium. Receptor number in right atria increased dramatically 1 and 2 days after left ventricular injury. Light microscopic autoradiography demonstrated that atrial fMLP binding sites were concentrated selectively in small, morphologically undifferentiated cells located in interstitial and perivascular spaces. This is the first demonstration of a formylated peptide receptor on a nonleukocytic cell. The observed increase in atrial fMLP binding sites provides a plausible mechanism for the enhanced fMLP-stimulated eicosanoid synthesis observed in rabbit hearts following left ventricular myocardial infarction.
Materials and Methods

Materials
fMLP, A^-formyl-norleucyl-leucyl-pheaylalanine (fNLP), and Af-T-boc-phenylalanyl-leucylphenylalanyl-leucyl-phenylalanine (Af-T-bocpheleupheleuphe) fMLP were purchased from Sigma Chemical, St. Louis, Missouri. [ 3 H](60 Ci/mmol) was purchased from New England Nuclear, Boston, Massachusetts. NTB-2 nuclear tract emulsion was purchased from Eastman Kodak, Rochester, New York. NCS tissue solubilizer was purchased from Amersham, Arlington Heights, Illinois. Other chemicals were reagent grade.
Surgical Myocardial Infarction
Left ventricular myocardial infarction was produced surgically in male white New Zealand rabbits (2-3 kg) by ligation of the distal left circumflex artery for 60 minutes followed by reperfusion, as described previously. 10 After surgery, the animals were allowed to convalesce for 1, 2, or 4 days.
Radioligand Binding Assay
Hearts were excised rapidly from heparinized (500 units i.v.) and anesthetized (sodium pentobarbital 90 mg7kg i.v.) animals and perfused via aortic cannulae with 20 ml ice-cold saline to remove blood. Left and right atria and left ventricle were dissected and frozen over dry ice, and transmural sections (12 /urn in thickness) were cut with a cryostat and mounted on gelatin-coated slides. Slidemounted sections were stored overnight at -20° C. 13 Greater than 95% of the radioactivity applied to the column was found to coelute with an unlabeled fMLP standard detected by ultraviolet spectrometry. To confirm the specificity of the assay, additional binding studies were performed using the fMLP analogues fNLP and 7V-Tboc-pheleupheleuphe as displacing ligands. Adsorbed radioactivity was removed selectively by incubating tissue sections in cold buffer for 5 minutes. The 5-minute washing period was found in preliminary experiments to result in maximal removal of adsorbed counts with no detectable loss of specifically bound radiolabel. In sections prepared for autoradiography, adsorbed radioactivity was removed by briefly washing the sections in cold buffer (10 seconds) and then dipping the sections into distilled water to remove buffer solutes. After washing, the sections were dried under a stream of air and radioactivity in the sections was quantified with scintillation spectrometry or autoradiography as described below.
Association and Dissociation Kinetics
Association kinetics were characterized by incubating slide-mounted tissue sections in 10 nM [ 3 H]fMLP in the presence or absence of 1 jiM unlabeled fMLP. After 0.5-60 minutes of incubation, sections were washed for 5 minutes in buffer at 4° C and dried, and radioactivity in each section was quantified by scintillation spectrometry. Dissociation (off-rate) kinetics were assessed by incubating sections in 10 nM [ 3 H]fMLP for 30 minutes, followed by addition of 1 /xM unlabeled fMLP to the incubation buffer. After 1-60 minutes of incubation, sections were washed and dried, and radioactivity was quantified. Sections were scraped from the slides with a razor blade and digested overnight in NCS tissue solubilizer (0.5 ml/section). Digested samples were adjusted to pH 7.0 with glacial acetic acid, and radioactivity was quantified with scintillation spectrometry using a scintillant consisting of 80 mM 2,5-diphenyloxazole, 0.27 mM l,4-bis(2-(5-phenyloxazolyl))benzene in toluene. Radioactivity per section was normalized per unit area (cm ) to account for modest variations in section area that occur during preparation of large numbers of serial sections. One of every six serial tissue sections was used for determination of area. These sections were photographed, the section outlines on photographic enlargements were traced, and areas were measured using a conventional computer-based planimeter.
Binding Isotherms
Tissue sections were incubated at 25° C for 30 minutes in incubation buffer containing 0. 
Receptor Autoradiography
The distribution of radioligand binding sites in slide-mounted tissue sections was assessed autoradiographically using the wire loop method of application of emulsion.
u Thin films of melted Kodak NTB-2 emulsion were picked up with a wire loop, allowed to harden, and then placed over the labeled sections. After drying at room temperature for 2 hours, sections were stored with dessicant in lighttight boxes at 4° C for 1-4 days. Exposed emulsions were developed with Kodak D-19 developer diluted 1:1 with water for 3 minutes at 25° C, fixed with Kodak fixer for 1 minute, rinsed with distilled water, stained with hematoxylin and eosin, and examined by light microscopy.
In autoradiography experiments aimed at defining cellular morphology, hearts from animals 1 day after myocardial infarction were rapidly frozen in a dry ice-isopentane bath. Frozen sections (12 yu.m) were cut, and groups of three serial sections of atria and ventricle were processed for [ 3 H]fMLP autoradiography (with and without displacer) and conventional hematoxylin and eosin staining or for [^HJfMLP autoradiography (with and without displacer) and Leder staining for granulocytic cells. Additional sections from these hearts were processed for nonspecific esterase staining to detect mononuclear leukocytes.
Results
Binding Assay Specificity and Kinetics
Initial studies were performed to validate the specificity of the [ To test the specificity of this assay, fNLP and iV-iV^T-boc-pheleupheleuphe were substituted as displacing ligands in the assay. In previously published data, fNLP has been shown to be an agonist with approximately 10% the potency of fMLP in a neutrophil chemotaxis assay (fMLP £00=7.0x10-" M; fNLP EQo=6.6 x 10~l ff M).i<> jV-T-boc-pheleupheleuphe has been shown to be a weak antagonist, with an IQo value of 6.4 xlO" 7 M in the neutrophil chemotaxis assay, 16 and a K x value of 0.7 fiM for displacement of fMLP in a neutrophil radioligand binding assay. 17 Consistent with this data, quantitatively similar amounts of nonspecific binding to tissue were observed in assays using unlabeled fMLP and fNLP (1 ^M) as displacing ligands. Also consistent with previous reports, A/-T-bocpheleupheleuphe was not as potent a displacer as the formylated peptides, and assays using this compound as the displacing agent showed increasing displacement of [H]fMLP binding over N-T-boc-pheleupheleuphe concentrations of 1-10 /JM. Estimated K v of iV-T-boc-pheleupheleuphe was 2-3 /xM. The results illustrate the specificity of this receptor assay and the appropriate use of unlabeled fMLP as a displacing ligand.
Binding Isotherms
To characterize fMLP receptors with respect to saturability, receptor affinity, and number, binding isotherms were performed in right atria and left ventricle from normal and infarcted hearts. A typical binding isotherm performed with tissue from the right atrium of an infarcted heart (2 day) is depicted graphically in Figure 2 . As in all tissue preparations, the right atrium demonstrated a high degree of specific binding (approximately 91% of total ligand bound). Receptor saturation was achieved in right atrial tissue at a <5 nM concentration of pHjfMLP with approximately 17 fmol bound/cm section area (specific). Curves generated from Scatchard analysis of binding isotherm data ( Figure 2) (Figure 3 ). These cells had large nucleus to cytoplasm ratios and exhibited no morphological features of nuclear or cytoplasmic differentiation. These cells did not appear to be resident macrophages, mast cells, or granulocytes. Indeed, mast cell specific stains and nonspecific esterase stains failed to reveal the presence of either mast cells or resident macrophages in right atrial sections.
Labeled interstitial cells in right atrial sections from normal and infarcted hearts had roughly equal numbers of grains, suggesting equivalent receptor densities. Differences were noted, however, in the total number of cells binding fMLP. Right atria from infarcted hearts contained many times more labeled cells than normal atria. The infarcted left ventricle contained necrotic myocytes and focal infiltrates of porymorphonuclear leukocytes (PMNs), features absent in normal zones of ventricles containing infarcts and in ventricles from normal hearts. Autoradiographic analysis of infarct zones revealed fMLP specific binding associated with PMNs (Figure 4 ) but no binding to ventricular myocytes.
To further characterize the identity of [ 
Discussion
The focus of this investigation was to characterize and localize formylated peptide binding sites in normal and infarcted rabbit hearts to better understand the mechanisms of enhanced fMLP-stimulated eicosanoid synthesis in the right atrium of infarcted hearts. Significant findings of these studies include identification of a specific formylated peptide receptor on a nonleukocytic cell type in rabbit right atrium and increased expression of this receptor after left ventricular myocardial infarction.
fMLP is a synthetic peptide that is related structurally to formylated-methionyl peptides found in prokaryotic cells. 18 It is a potent chemoattractant for PMNs and macrophages 19 and stimulates eicosanoid synthesis by these cells. 9 Consistent with these biological effects, fMLP receptors have previously been identified only on inflammatory cells.
20 - 22 The current study clearly demonstrates the existence of a saturable high affinity fMLP receptor in the right atrium. The absence of histologically apparent inflammatory cells in rabbit right atrium (from both normal and infarcted hearts) coupled with autoradiographic localization studies indicates that this fMLP receptor is associated with neither inflammatory cells nor atrial myocytes. Indeed, the localization of this receptor to a morphologically undifferentiated interstitial cell pro- vides the first demonstration of an fMLP receptor on a nonleukocytic cell.
The precise identity of the fMLP binding cell is not clearly delineated by the current studies. Based on its distribution in interstitial and perivascular spaces and on its nondescript morphology, we hypothesize that this cell is a cardiac mesenchymal cell. 23 Unfortunately, no specific biochemical, ultrastructural, or immunological markers are known for mesenchymal cells, precluding direct confirmation of this hypothesis. As fMLP has been shown to stimulate eicosanoid synthesis in rabbit right atrium, 12 the fMLP binding cell should possess the enzymatic machinery for arachidonate metabolism. Indeed, previous work has shown that cardiac arachidonate metabolizing enzymes are preferentially localized to the mesenchymal cells. 23 A striking result of this investigation is that ventricular myocardial infarction results in increased fMLP receptor expression (B^ in the right atrium. Such an increase in B^ could be due to increased receptor number (new synthesis) by cells already expressing receptor or an increase in the number of cells expressing receptor. Alternatively, the increased B^ could result from a conversion of preexisting low affinity receptors to a high affinity state. This latter mechanism is possible because the radioligand used is an agonist and only detects high affinity binding. It is unlikely that the increased Br esults from translocation of intracellular receptors to the plasma membrane since intracellular receptors are likely to be accessible to the radioligand in the 12 jam sections. Qualitative analysis of receptorautoradiograms demonstrated that the amount of fMLP (estimated from silver grain density) bound to individual atrial cells from normal and infarcted hearts was roughly equal but that the number of labeled ceUe ia atria from infarcted hearts was significantly greater than in the normal right atrium. This increase in the number of cells binding fMLP could result either from an increase in the number of resident cells expressing high affinity receptors or from proliferation or accumulation of fMLP binding cells following infarction. Which of these mecha- nisms is operative is not addressed by the current studies and is a question likely to be answered more readily in tissue culture than in vivo.
Regardless of the mechanism of increased receptor expression, it is clear that the right atrium senses and responds to left ventricular injury. The temporal relation between the influx of PMNs into the infarcted ventricle and the increase in right atrial fMLP receptor number suggests that a soluble factor from inflammatory cells in the ventricle may induce increased atrial receptor expression. This is consistent with our recent observation that myocardial infarction in leukopenic rabbits results in decreased ventricular inflammation coupled with an attenuated atrial eicosanoid synthetic response to fMLP and attenuated increases in atrial fMLP receptor number. Precedent does exist for soluble factors influencing fMLP receptor number. In rabbit and guinea pig PMNs, endotoxin has been shown to increase fMLP receptor number.-Similarly, in human PMNs, increased intracellular calcium concentration has been shown to increase fMLP receptor number, whereas phorbol myristate has been shown to decrease receptor number. Other mechanisms by which left ventricular injury might influence atrial receptor expression include a neural or systemic hormonal response to ventricular injury or a direct mechanical effect (e.g., increased right atrial pressure) of ventricular injury.
The potential pathophysiological significance of increased fMLP receptor expression in the right atrium of hearts with left ventricular injury is unknown. This question is complicated by the absence of information on the function of mesenchymal cells in the right atrium. While it seems unlikely that fMLP itself is a significant mediator in myocardial infarction, it will be of interest to determine if atrial receptors for other mediators of inflammation (e.g., kinins and complement anaphylotoxins) are also modulated by left ventricular injury. Our previous demonstration of increased eicosanoid synthetic response to bradykinin in the right atria of hearts with left ventricular injury makes this a reasonable possibility. The right atrium does play an important role in blood volume regulation, serving both as a sensory organ through its stretch receptors and as an effector organ through secretion of atriopeptins. The localization of the sinoatrial node in the right atrium also makes this chamber uniquely important in the generation of the cardiac impulse. Thus, it will be of interest to determine if increased atrial expression of receptors for inflammatory mediators (and the attendant exaggerated eicosanoid synthetic response) plays a role unusual communication between ventricle and atria and to unravel the pathophysiological significance of this phenomenon.
